High rate of drug resistance among tuberculous meningitis cases in Shaanxi province, China.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27143630)

Published in Sci Rep on May 04, 2016

Authors

Ting Wang1,2, Guo-Dong Feng1, Yu Pang3, Jia-Yun Liu4, Yang Zhou3, Yi-Ning Yang1, Wen Dai1, Lin Zhang1, Qiao Li1, Yu Gao1, Ping Chen1, Li-Ping Zhan2, Ben J Marais5, Yan-Lin Zhao3, Gang Zhao1

Author Affiliations

1: Department of Neurology, Xijing Hospital, the Fourth Military Medical University, no.169 Changle West Road, Xi'an, Shaanxi, 710032, P.R.China.
2: Department of Neurology, Kunming Medical University affiliated Yan'an Hospital, 245 Renming East Road, Kunming, Yunnan, 650200, P.R.China.
3: National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, no.155 Changbai Road, Beijing, 102206, P.R.China.
4: Department of Inspection, Xijing Hospital, Fourth Military Medical University, no.169 Changle West Road, Xi'an, Shaanxi, 710032, P.R.China.
5: The Children's Hospital at Westmead and the Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Australia.

Articles cited by this

Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med (2010) 32.89

Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. J Clin Microbiol (1988) 28.11

Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol (2006) 12.53

MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE. Bull World Health Organ (1963) 9.26

Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clin Microbiol Rev (2004) 7.95

Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol (1998) 7.84

National survey of drug-resistant tuberculosis in China. N Engl J Med (2012) 6.28

Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Lancet Infect Dis (2010) 5.14

Tuberculosis in children. N Engl J Med (2012) 4.07

Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2005) 3.01

Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis. J Clin Microbiol (2006) 2.88

Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis (2010) 2.86

The rpsL gene and streptomycin resistance in single and multiple drug-resistant strains of Mycobacterium tuberculosis. Mol Microbiol (1993) 2.48

Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis (2005) 2.29

Tuberculous meningitis: more questions, still too few answers. Lancet Neurol (2013) 2.26

New susceptibility breakpoints for first-line antituberculosis drugs based on antimicrobial pharmacokinetic/pharmacodynamic science and population pharmacokinetic variability. Antimicrob Agents Chemother (2010) 1.95

Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis. J Clin Microbiol (2013) 1.62

Rise in rifampicin-monoresistant tuberculosis in Western Cape, South Africa. Int J Tuberc Lung Dis (2012) 1.47

Spoligotyping and Mycobacterium tuberculosis. Emerg Infect Dis (2005) 1.46

Phenotypic and genotypic analysis of multidrug-resistant tuberculosis in Ethiopia. Int J Tuberc Lung Dis (2010) 1.45

Distribution of the Beijing family genotypes of Mycobacterium tuberculosis in Taiwan. J Clin Microbiol (2005) 1.38

Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal. PLoS Med (2015) 1.33

Mycobacterium tuberculosis strains of the modern sublineage of the Beijing family are more likely to display increased virulence than strains of the ancient sublineage. J Clin Microbiol (2014) 1.18

Rapid diagnosis of tuberculosis and multidrug resistance using a MGIT 960 system. Ann Lab Med (2012) 1.13

Tuberculous meningitis in adults: a review of a decade of developments focusing on prognostic factors for outcome. Future Microbiol (2012) 1.11

Molecular profile of drug resistance in tuberculous meningitis from southwest china. Clin Infect Dis (2011) 1.09

A highly efficient Ziehl-Neelsen stain: identifying de novo intracellular Mycobacterium tuberculosis and improving detection of extracellular M. tuberculosis in cerebrospinal fluid. J Clin Microbiol (2012) 0.95

The Clinical Features and Bacteriological Characterizations of Bone and Joint Tuberculosis in China. Sci Rep (2015) 0.93

Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review. PLoS One (2015) 0.90

Added value of whole-genome sequencing for management of highly drug-resistant TB. J Antimicrob Chemother (2014) 0.89

Comparison of real time IS6110-PCR, microscopy, and culture for diagnosis of tuberculous meningitis in a cohort of adult patients in Indonesia. PLoS One (2012) 0.89

Improving detection and notification of tuberculosis cases in students in Shaanxi province, China: an intervention study. BMC Public Health (2011) 0.88

Detection of Mycobacterium tuberculosis GlcB or HspX Antigens or devR DNA impacts the rapid diagnosis of tuberculous meningitis in children. PLoS One (2012) 0.88

Diagnostic accuracy of intracellular mycobacterium tuberculosis detection for tuberculous meningitis. Am J Respir Crit Care Med (2014) 0.88

The global tuberculosis situation and the inexorable rise of drug-resistant disease. Adv Drug Deliv Rev (2016) 0.88

Screening for streptomycin resistance-conferring mutations in Mycobacterium tuberculosis clinical isolates from Poland. PLoS One (2014) 0.87

Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment. Eur Respir J (2015) 0.87

Molecular genotyping of Mycobacterium tuberculosis in Xi'an, China, using MIRU-VNTR typing. Int J Tuberc Lung Dis (2011) 0.86

Phenotypic and genotypic analysis of anti-tuberculosis drug resistance in Mycobacterium tuberculosis isolates in Myanmar. Ann Lab Med (2015) 0.86

The diagnostic value of cerebrospinal fluid chemistry results in childhood tuberculous meningitis. Childs Nerv Syst (2015) 0.86

Genotypes and transmitted drug resistance among treatment-naive HIV-1-infected patients in a northwestern province, China: trends from 2003 to 2013. PLoS One (2014) 0.83

Clinical value of whole-genome sequencing of Mycobacterium tuberculosis. Lancet Infect Dis (2015) 0.83

Drug-resistant tuberculous meningitis. Expert Rev Anti Infect Ther (2013) 0.82

Temporal dynamics of Mycobacterium tuberculosis genotypes in New South Wales, Australia. BMC Infect Dis (2014) 0.81

Multidrug-Resistant Tuberculosis in Patients for Whom First-Line Treatment Failed, Mongolia, 2010-2011. Emerg Infect Dis (2015) 0.81

Culture positive tuberculous meningitis: clinical indicators of poor prognosis. Clin Neurol Neurosurg (1999) 0.80

Transcriptional and proteomic analyses of two-component response regulators in multidrug-resistant Mycobacterium tuberculosis. Int J Antimicrob Agents (2015) 0.80

Prospective Analysis of 55 Cases of Tuberculosis Meningitis (TBM) in North India. J Clin Diagn Res (2015) 0.80

Genotypic and phenotypic characteristics of aminoglycoside-resistant Mycobacterium tuberculosis isolates in Latvia. Diagn Microbiol Infect Dis (2014) 0.79

Purification and characterization of Mycobacterium tuberculosis KatG, KatG(S315T), and Mycobacterium bovis KatG(R463L). Protein Expr Purif (2004) 0.78

The Association between Mycobacterium Tuberculosis Genotype and Drug Resistance in Peru. PLoS One (2015) 0.78

Patterns of drug resistance in pulmonary tuberculosis cases in the Izmir district, Turkey. New Microbiol (2009) 0.76

[A survey on resistance to second-line drugs in patients with pulmonary tuberculosis in Shanghai, China]. Zhonghua Jie He He Hu Xi Za Zhi (2011) 0.76

Outcomes of Category I and II regimens in mono- and polyresistant tuberculosis cases in the Philippines. Int J Tuberc Lung Dis (2016) 0.76

[Clinical features and antibiotic resistance of Escherichia coli bloodstream infections in children]. Zhonghua Er Ke Za Zhi (2016) 0.76

Proposal of a Screening MIRU-VNTR Panel for the Preliminary Genotyping of Mycobacterium bovis in Mexico. Biomed Res Int (2015) 0.75